“PO86 | Emicizumab in Patients With Moderate Hemophilia A and Severe Bleeding Phenotype: Single-Center Real-World Experience: A.L. Faccini, M. Biglietto, S. Sorella, E. Crisanti, M. Antonacci, R. Mormile, R. Ciciani, E. Baldacci, C. Santoro, S. Ligia | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy”. Bleeding, Thrombosis and Vascular Biology 4, no. s1 (August 5, 2025). Accessed August 6, 2025. https://www.btvb.org/btvb/article/view/355.